Somatropin biosimilar - Inbiopro SolutionsAlternative Names: IBPB 003HH
Latest Information Update: 16 Aug 2013
At a glance
- Originator Inbiopro Solutions
- Class Growth hormones; Hormonal replacements; Proteins
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Somatotropin deficiency
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 30 Jun 2012 Clinical trials in Somatotropin deficiency (childhood onset and adulthood onset) in India (unspecified route)